Roxanne Austin

(Ms. Roxanne Austin)

Occupe actuellement des postes chez Abbott Laboratories, Teledyne Technologies Inc, Abbvie Inc and Target Corp

Postes
Position Company Period
Independent Director Abbott Laboratories 8 décembre 2000 -
Independent Director Teledyne Technologies Inc 10 octobre 2006 -
Independent Director Abbvie Inc 2 janvier 2013 -
Independent Director Target Corp 12 août 2014 -
Independent Director Telefonaktiebolaget LM Ericsson 3 mars 2008 - 13 avril 2016
Independent Interim Non-Executive Chairman of the Board Target Corp 5 mai 2014 - 12 août 2014
Independent Director Target Corp 1 janvier 2002 - 5 mai 2014
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Nb. d'actions
Prix
Valeur
Nombre d'actions Prix Valeur totale Détails
2024-02-09 2024-02-09
VP Vente planifiée
6 303 -6.7%
21,54
135 767 USD
6 303 -6.7% 21,54 135 767 USD
2024-01-10 2024-01-09
VP Vente planifiée
6 303 -6.2%
22,58
142 322 USD
6 303 -6.2% 22,58 142 322 USD
2023-10-13 2023-10-11
V Vente
5 000 -22.1%
185,25
926 250 USD
5 000 -22.1% 185,25 926 250 USD
2023-10-10 2023-10-10
V Vente
5 000 -18.1%
185,01
925 050 USD
5 000 -18.1% 185,01 925 050 USD
2023-10-11 2023-10-09
VP Vente planifiée
6 303 -5.3%
19,20
121 018 USD
6 303 -5.3% 19,20 121 018 USD
2023-10-10 2023-10-06
V Vente
5 000 -15.3%
172,25
861 250 USD
5 000 -15.3% 172,25 861 250 USD
2023-10-10 2023-10-06
V Vente
5 000 -13.3%
172,01
860 050 USD
5 000 -13.3% 172,01 860 050 USD
2023-09-12 2023-09-11
VP Vente planifiée
6 303 -5.0%
22,07
139 107 USD
6 303 -5.0% 22,07 139 107 USD
2023-08-10 2023-08-09
VP Vente planifiée
6 298 -4.8%
21,47
135 218 USD
6 298 -4.8% 21,47 135 218 USD
2023-07-12 2023-07-10
VP Vente planifiée
6 303 -4.6%
16,19
102 046 USD
6 303 -4.6% 16,19 102 046 USD
2023-07-03 2023-07-03
VP Vente planifiée
7 962 -5.5%
17,35
138 141 USD
7 962 -5.5% 17,35 138 141 USD
2023-06-09 2023-06-09
VP Vente planifiée
25 212 -15.9%
15,76
397 341 USD
25 212 -15.9% 15,76 397 341 USD
2023-02-21 2023-02-17
US Abbvie Inc (ABBV)
V Vente
10 000 -19.7%
150,50
1 505 000 USD
10 000 -19.7% 150,50 1 505 000 USD
2023-02-14 2023-01-05
A Achat
15 500 +15.4%
99,00
1 534 500 USD
15 500 +15.4% 99,00 1 534 500 USD
2023-01-06 2023-01-05
A Achat
15 000 +17.6%
97,59
1 463 900 USD
15 000 +17.6% 97,59 1 463 900 USD
2023-01-06 2023-01-05
A Achat
20 000 +30.6%
95,14
1 902 800 USD
20 000 +30.6% 95,14 1 902 800 USD
2022-12-29 2022-12-28
A Achat
10 000 +18.0%
99,31
993 100 USD
10 000 +18.0% 99,31 993 100 USD
2022-12-29 2022-12-27
A Achat
15 000 +37.1%
100,03
1 500 401 USD
15 000 +37.1% 100,03 1 500 401 USD
2021-11-04 2021-11-03
US Abbvie Inc (ABBV)
V Vente
20 000 -28.9%
117,23
2 344 600 USD
20 000 -28.9% 117,23 2 344 600 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
V Vente
6 844 -9.0%
115,23
788 634 USD
6 844 -9.0% 115,23 788 634 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
V Vente
25 000 -24.7%
116,11
2 902 750 USD
25 000 -24.7% 116,11 2 902 750 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
V Vente
20 000 -16.5%
117,10
2 342 000 USD
20 000 -16.5% 117,10 2 342 000 USD
2021-10-18 2021-10-14
V Vente
10 000 -38.5%
274,75
2 747 500 USD
10 000 -38.5% 274,75 2 747 500 USD
2020-12-08 2020-12-07
V Vente
35 000 -57.1%
170,00
5 950 000 USD
35 000 -57.1% 170,00 5 950 000 USD
2020-10-14 2020-10-12
V Vente
8 000 -15.4%
149,23
1 193 840 USD
8 000 -15.4% 149,23 1 193 840 USD
2020-10-07 2020-10-05
V Vente
2 000 -3.7%
145,73
291 460 USD
2 000 -3.7% 145,73 291 460 USD
2019-08-02 2019-08-01
US Abbvie Inc (ABBV)
A Achat
25 000 +27.1%
65,66
1 641 400 USD
25 000 +27.1% 65,66 1 641 400 USD
2019-08-02 2019-07-31
US Abbvie Inc (ABBV)
A Achat
30 000 +48.3%
66,02
1 980 690 USD
30 000 +48.3% 66,02 1 980 690 USD
2019-07-31 2019-07-30
US Abbvie Inc (ABBV)
A Achat
10 000 +19.2%
66,35
663 500 USD
10 000 +19.2% 66,35 663 500 USD
2019-06-28 2019-06-26
US Abbvie Inc (ABBV)
A Achat
11 500 +28.3%
67,50
776 250 USD
11 500 +28.3% 67,50 776 250 USD